Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group study.
Thomas NyströmIrene Santos-PardoXin FangDhanisha Jayesh TrivediFredric HedbergJohan JendlePublished in: Endocrinology, diabetes & metabolism (2019)
Liraglutide treatment increased diurnal variation in hourly mean HR followed by an increase in mean daytime HR, independently of changes in sympathetic or parasympathetic activity.